BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22796778)

  • 1. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia.
    Kuo YC; Wang CC
    Colloids Surf B Biointerfaces; 2013 Jan; 101():101-5. PubMed ID: 22796778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
    Kuo YC; Wang CC
    Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles.
    Kuo YC; Chen HH
    Int J Pharm; 2009 Jan; 365(1-2):206-13. PubMed ID: 18848610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells.
    Kuo YC; Chen HH
    J Drug Target; 2010 Jul; 18(6):447-56. PubMed ID: 20528098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
    Kuo YC; Ko HF
    Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
    Kuo YC; Chung CY
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):682-90. PubMed ID: 21865017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
    Kuo YC; Yu HW
    Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: effect of surfactant composition.
    Kuo YC; Wang CC
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):286-91. PubMed ID: 20004085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
    Kuo YC; Su FL
    Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethyl ammonium bromide.
    Kuo YC; Lin SC
    J Phys Chem B; 2008 Apr; 112(14):4454-60. PubMed ID: 18345661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies.
    Dodiya SS; Chavhan SS; Sawant KK; Korde AG
    J Microencapsul; 2011; 28(6):515-27. PubMed ID: 21728760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
    Kuo YC; Kuo CY
    Int J Pharm; 2008 Mar; 351(1-2):271-81. PubMed ID: 17976933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
    Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
    J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
    Kuo YC; Yu HW
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):627-34. PubMed ID: 21855303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Kuo YC; Lee CL
    Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
    Kuo YC; Yu HW
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
    Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
    Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles.
    Kigen G; Edwards G
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):79. PubMed ID: 30509316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Kuo YC; Chung JF
    Colloids Surf B Biointerfaces; 2011 Apr; 83(2):299-306. PubMed ID: 21194902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.
    He Y; Xia DN; Li QX; Tao JS; Gan Y; Wang C
    Acta Pharmacol Sin; 2015 Sep; 36(9):1151-60. PubMed ID: 26256404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.